Aguilar SSI, Bautista SL, Saldaña CMM

Language: Spanish
References: 20
Page: 32-37
PDF size: 292.05 Kb.

ABSTRACT

Introduction: genesis of the Metabolic Syndrome (MS) involves risk factors and chronic diseases such as: Diabetes Mellitus (DM), Systemic Arterial Hypertension (SAH) and obesity. The lifestyle is the cornerstone for its management, in which the Primary Care physician can influence. Objective: to identify effectiveness between physical activity lifestyle and exercising in order to control clinic and metabolic the carrier of MS. Material and methods: quasi-experimental study in 60 beneficiaries of the Family Medicine Unit (FMU) no. 94 of the Mexican Institute of the Social Security (IMSS) aged between 18 and 59 years. Sampling by intention under informed consent, diagnosed MS. There were 15 people in group “A” (physical exercise) and 45 in group “B” (physical activity). Clinical indicators were considered such as: Body Mass Index (BMI), Blood Pressure (BP) and the abdominal circumference; they were taken into account at the beginning of the study, at the second and fourth months and the chemicals: cholesterol, Triglycerides (TG) and peripheral glucose. Descriptive statistics and U tests of Mann-Whitney, Wilcoxon and Kruskal-Wallis were used. Results: the average age of group “A” was 41.56 +- 11.98 years old, and of group “B” 40.73 +- 12.57 years old; in both groups prevailed married as marital status and studies up to primary school. According to the group of study, the clinic parameters showed that BP improved in 43% (A) and 40% (B); the metabolic indicators: cholesterol 66% (A) and TG 42% (B). Bad initial effectiveness 60% (A) and regular 51% (B); at the end in both groups were: regular 80% (A) and 73% (B), p 0.001 for school age and smoking p›0.05. Conclusions: it was corroborated that a physical exercise routine is more effective than physical activity in order to control clinic and metabolic carriers of MS, because it was found a statistically important difference in the results.

REFERENCES

1. González-Chávez A, Alexanderson-Rosas EG, Alvarado-Ruiz R, Becerra-Pérez AR, Camacho-Aguilera J, Carmona-Solis K. y cols. Consenso mexicano sobre el tratamiento integral del síndrome metabólico. Rev Mex Cardiol. 2002;13(1):4-30.

2. Definición mundial de consenso para el síndrome metabólico. Rev Panam Salud Publica/Pan Am J Public Health.2005;18(6):451-54.

3. Cabale-Vilariño MB, Sánchez-Serrano CD, Flores- Sánchez A. Prevalencia del síndrome metabólico en dislipidémicos. Rev Cubana Med.2006;45(3):1-9.

4. Deen D. Metabolic syndrome: time for action. Am Fam Physician.2004 jun;69(12):2875-82.

5. Ramírez-Vargas E, Arnaud-Viñas MR, Deslile H. Prevalence of the metabolic syndrome and associated lifestyles in adults males from Oaxaca, México. Salud Pública Mex. 2007;49(2):94-102.

6. Echeverría-Pinto M, Hernández-Lomeli MA, Alcocer-Gamba MA, Morales-Flores H, Vázquez-Mellano A. Síndrome metabólico en adultos de 20 a 40 años en una comunidad rural mexicana. Rev Med Inst Mex Seguro Soc.2006;44(4):329-35.

7. Romero CE. El síndrome metabólico. Rev Med Urug.2006;22:108-21.

8. Gonzalez A, Becerra AR, Carmona FK, Cerezo MIA. Ejercicio físico para la salud. Rev Mex Cardiol. 2001;12(4):168-80.

9. León AS, Sánchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc.2001 jun;33(6 suppl): S502-15,discussion S528-9.

10. European Society of Hypertension-European Society of Cardiology. Guidelines for management of arterial hypertension. J. Hipertensión.2003;21 jun:1011-53.

11. Saucedo-Rodrigo P, Abellán-Alemán J, Gómez-Jara P, Leal-Hernández M, Ortega-Toro E, Colado- Sánchez JC y cols. Efectos de un programa de ejercicio físico sobre la calidad de vida en la postmenopausia. Arch Med Fam.2009;11(1):3-10.

12. Clark DO. Physical activity efficacy and effectiveness among older adults and minorities. Diabetes Care.1997 jun;20(7):1176-82.

13. Perri MG, Martin AD, Leermakers EA, Sears SF, Notelovitz M. Effects of group versus home based exercise in the treatment of obesity. Consult Clin Psychol.1997 apr;65(2):278-85.

14. Saldaña-Cedillo MM, Bautista-Samperio L. Síndrome de resistencia a la insulina: una perspectiva desde la medicina familiar. Arch Med Fam.2004;6(3);64-65.

15. González-López EM, Bautista-Samperio L, Irigoyen-Coria AE. Identificación de factores de riesgo para síndrome metabólico en población aparentemente sana de una Unidad de Medicina Familiar en la ciudad de México. Arch Med Fam. 2009:11(3):27-42.

16. Corona-Hernández B, Bautista-Samperio L. Perfil del paciente diabético en una Unidad de Medicina Familiar de la ciudad de México. Arch Med Fam. 2004;6(2):40-3.

17. Instituto Mexicano del Seguro Social. Diagnóstico de salud, delegación 2 Noroeste del Distrito Federal. Unidad de Medicina Familiar No. 94: Sistema de Información Médica 2007.

18. Gómez-Pérez FJ, Ríos-Torres JM, Aguilar-Salinas CA, Lerman-Garber I, Rull-Rodrigo JA. Posición de la SMNE sobre el manejo del síndrome metabólico (2° parte). Rev Endocrinol Nutr.2005;13(1):9-23.

19. Crepaldi G, Maggi S. Diabetes y síndrome metabólico: contexto histórico. Diabetes Voice. 2006;51:8-10.

20. González-Chávez A, Alexánderson-Rosas EG, Alvarado- Ruiz R, Ayub-Ayala M, Camacho-Aguilera J, Cardona-Muñoz EG, y cols. Consenso mexicano de resistencia a la insulina y síndrome metabólico. Revista Mexicana de cardiologia.1999;10(1):3-19.